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Abstract
Nowadays cancer is one of the main reasons of death all over the world and it is estimated that deaths caused by
cancer will grow dramatically in the next decades. Even if chemotherapy is the election therapy for solid tumors, as
well as leukemias and lymphomas, cancer treatments are in continuous evolution trying to solve the problem of
resistance mainly due to low accumulation of the drug in tumor cells (MDR). Natural compounds represent a valid
alternative to treat several disease and recently the scientific community focus on these natural compounds and
plant metabolites with therapeutic activities and low toxicities compared with synthetic ones.
A combination therapy, that join conventional chemotherapy with natural plant metabolites, is now considered a
new promising strategy to overcome MDR and reduce cellular toxicity; in particular, in leukemia due to its very
complex origin and development of leukemogenesis.
Here, we want to summarize and update the recent applications of natural compounds in the treatment of
leukemia.
Introduction
Nowadays, cancer is one of the main reason of death all over the
world owing to late diagnosis, poor prognosis and, frequently, drug
resistance. About 6 million people die of cancer each year, and it is
among the leading causes of death worldwide; it is estimated that
deaths caused by cancer will grow dramatically in the next decades.
Leukemia is an hematological disease caused by persistence of
immature white blood cells in different district of the organism mainly
bone marrow, lymph node, spleen and circulating blood. These
immature white blood cells can proliferate generating the acute form of
leukemia; otherwise, leukemia is due to the action of mature cells and
in this case will be chronic leukemia. According to the cell lineage
transformation and clinical characteristics, leukemia is classified in
acute myeloid leukemia (AML), chronic myeloid leukemia (CML),
acute lymphocytic leukemia (ALL) and chronic lymphocytic leukemia
(CLL).
Chemotherapy is the election therapy for solid tumors, as well as
leukemia and lymphomas [1]. Cancer treatments are in continuous
evolution trying to solve the problem of low accumulation of the drug
in tumor cells. Multidrug resistance (MDR) of tumor cells is often
associated with an overexpression of ATP-binding cassette (ABC)
transporter proteins that caused an ATP-dependent decrease in
cellular drug accumulation [2]. Anticancer drugs, which elude the
ABC transporters, could be a solution for drug resistance. Natural
Compounds that reverse the resistance against anticancer drugs are
considered multi-drug resistance (MDR) inhibitors or MDR
modulators [3]. Recently, there is increased interest to identify
multidrug resistance reversal compounds from plants having low or no
side effects for use in cancer treatments [2].
It is evident that the ability to deliver the drug to target cells could
be decisive to eradicate cancer. For this reason, nanotechnology-based
drug delivery system seems to be very promising. Recently, some
nanoparticles have been produced to hit specifically the bulk of the
tumor, thanks to the use of specific markers for tumor targeted [4].
Moreover, in the last few years, the scientific community have
described in edible plants the presence of exosomes that contain
and/or carry pharmacological active molecules; for this reason, in 2014
the Food and Agriculture Organisation of the United Nations (FAO)
created a database that describe the presence of exosomes in food,
called FoodEVs. Exosomes are natural nanovesicles derived from
intracellular late endosomes [5] that have been used as vehicle for
therapeutic drug and gene delivery due to its versatility [6].
Accumulating evidence demonstrated that cancer cells release higher
levels of exosomes suggesting their involvement in cancer progression
and microenvironment education [7,8]. Leukemia derived exosomes
can also affect bone marrow microenvironment thus enhancing
leukemia cell growth [9-11]. We will discuss the anticancer effects of
plants extracellular vesicles in a following section.
Many medicinal plants has been used yet in the past decades to treat
several diseases due to their cardioprotective, hepatoprotective and
antidiabetic activities [12]. Recently, the scientific community focus on
natural compounds and plant metabolites with therapeutic activities,
mainly phytochemicals such as polyphenolic, terpenes and lignans
compounds, as new potential chemopreventive agents with cytotoxic
activity, multidrug resistance reverting potential or apoptotic effects on
cancer [13]. Furthermore, a combination therapy, that join
conventional chemotherapy with natural plant metabolites, is now
considered a new promising strategy to overcome MDR and reduce
cellular toxicity; in particular, in leukemia due to its very complex
origin and development of leukemogenesis.
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Here, we want to summarize and update the recent applications of
natural compounds in the treatment of leukemia.
Anti- Leukemic Activities of Natural Compounds
Produced By Plants
Polyphenols
Polyphenols are an important group of phytochemicals present in
the plant kingdom that exert multiple protective functions against
cellular oxidation, inflammation, aging, tumor initiation and
progression. Recently, it was demonstrated that a diet with a regular
consumption of fruits and vegetables, rich in polyphenols, significantly
reduces the risk of many cancers. Some of the polyphenols studied for
their anticancer potential are flavones, flavonols, isoflavones, and
catechins. Tannins, present in many plant foods, are polyphenols that
possess anticarcinogenic and antimutagenic potentials. It was
demonstrated that the tannin resveratrol (3, 5, 4´-trihydroxystilbene),
found in grapes and red wine, exhibits chemopreventive effects.
Resveratrol is known to down regulate the high endogenous level of
Heat shock protein 70 (Hsp70) in Chronic Myelogenous Leukemia
K562 cells and induce apoptosis. It was demonstrated that resveratrol
acts downstream of Bcr-Abl and inhibits Akt activity. This brings down
the transcriptional activity of HSF1 and Hsp70 production in K562
cells [14].
In this section, among the polyphenols, we will discuss the role of
Curcuminoids and Flavonoids.
Curcuminoids
These compounds are pigments present in dried rhizomes of
Curcuma longa and are responsible for the yellow color of the plants.
There are three compounds known as curcuminoids: curcumin,
demethoxycurcumin, and bis-demethoxycurcumin [15]. We focus our
attention on the role of curcumin, considered the king of spices.
curcumin is a natural dietary polyphenol with documented anti-
inflammatory, antioxidant and antineoplastic properties [16]; it is the
most commonly used spice in India and in Ayurveda and traditional
chinese medicine [17]. Several papers demonstrated that curcumin
affects different steps of cancer progression. curcumin has been shown
to be a strong suppressor of NF-kB that in turn down regulates the
expression levels of NF-κB-regulated gene products; it inhibits the
activation of IkB kinase (IKK) and, thus, prevents the phosphorylation
of IkB and the subsequent translocation of NF-kB to the nucleus [17].
Curcumin also enhances cell death or apoptosis via inhibition of the
MAPKs pathway, which includes c-Jun N-terminal kinases (JNKs) and
extracellular signal-regulated kinases (ERKs) [16]. Moreover, Shah and
colleagues indicate that Curcumin, as natural source, is able to
overcome drug resistance as well as to reduce cytotoxicity profile of
the conventional drug in Acute Myeloid Leukemia patients. They show
that curcumin down regulates MDR genes, such as MDR1, LRP, BCRP
and it has a synergistic effect in combination with cytarabine on
primary leukemic cells. These data suggest that curcumin can be used
as MDR modulator or chemosensitizer in combination with standard
chemotherapeutic drug cytarabine [18].
It was found that curcumin induces expression of interferon
regulatory genes (IFIT2) in leukemia cell lines. In leukemia, cells
treated with IFNγ increased apoptosis and enhanced anticancer effect
of curcumin. Conversely, shRNA-IFIT2 knockdown inhibited
curcumin-induced apoptosis in U937 leukemia cells. These results
demonstrated that there is a cross-talk between curcumin and
interferon signaling pathways, which provides the basis for a new
potential therapeutic approach, with curcumin combined to interferon
[19].
Recent papers demonstrated that curcumin can induce epigenetic
alteration such as changes in DNA methylation, histone modifications
and modulation of several oncogenic and tumor suppressor
microRNAs (miRNAs) expression such as miR-21, miR-20a,
miR-17-5p, and miR-27a and miR-34 a/c [20].
Our research group showed, in in vitro and in vivo models, that
treatment of CML cells with curcumin caused a miR-21-mediated
modulation of PTEN/AKT pathway leading to the inhibition of
leukemic cell growth. Curcumin affected the malignant properties of
CML cells through a disposal of miR-21 in exosomes released by CML
cells. Curcumin also induced the up-regulation of miR-196b and a
decrease of BCR-ABL at mRNA and protein level. For these reasons,
curcumin can be considered a promising compound that in association
with conventional tyrosine kinase inhibitor, may improve the
therapeutic approach for CML patients resistant to Imatinib [21].
Moreover, exosomes containing miR-21 and released by CML cells
treated with curcumin were able to modulate the endothelial barrier
organization and attenuated the angiogenic phenotype. These data
suggest that curcumin could be a potential therapeutic agent for CML
treatment with a double effect, on cancer cells and on tumor
microenvironment [22].
Figure 1: Effects of natural compounds on leukemia.
Numerous papers documented the protective effects of curcumin in
leukemia malignancy. Pimentel-Gutiérrez and colleagues
demonstrated, in Acute lymphoblastic leukemia (ALL), the potential
effect of curcumin as pharmacological co-adjuvant of several
chemotherapeutic agents used in ALL therapy [23].
There is a growing demand to find new therapeutic compounds that
show not only lower toxicity but also more solubility and
bioavailability. To answer to this request, recently different research
groups work to develop derivates of natural compounds with these
characteristics (Figure 1). It was identified a novel curcumin derivative
with more potent antitumor activity than curcumin. This compound
was shown to promote cell cycle arrest, at the G2/M phase, inducing
apoptosis in the MDR chronic myeloid leukemia cell line [24].
A recent paper described the development of a stable polymeric
micellar formulation of curcumin with improved solubility and
stability and suitable, for this reason, for clinical applications in
leukemia patients. Intracellular uptake to leukemic cells of curcumin-
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loaded polymeric micelles (CM-micelles) was higher than that of CM-
DMSO; moreover, CM-micelles have a significantly higher cytotoxic
activity than curcumin dissolved in DMSO on leukemic cells [25].
Flavonoids
Flavonoids are a class of polyphenolic compounds recently revalued
for their anticancer properties. They can be used as adjuvant agents for
cancer, in combination with conventional chemotherapy.
Luteolin: is a flavone isolated from the leaves of dandelion and sage
plants but it is also contained in carrots, fennen and celery. Luteolin is
widely studied because of its anti-cancer properties already
demonstrated on different models of solid tumors [26,27]. The
cytotoxic effect of luteolin was demonstrated recently also on two
human CLL cell lines, HG-3 and EHEB. Sak and others demonstrated
that Luteolin’s effect on human CLL cell lines is due to the activation of
the intrinsic apoptotic pathway mediated by caspases 3 and 9.
Moreover other two flavonols, fisetin and quercetin, probably due to a
specific binding to the cellular targets of signaling pathway induced by
luteolin, are able to increase the cytotoxic activity of luteolin in both
cell lines thus allowing that luteolin begin more effective at lower doses
[28].
Artocarpesin and cycloartocarpesin are two flavones isolated from
Artocarpus heterophyllus or jackfruit, a tree belonging from the family
of Moraceae and native of South and Southeast Asia.
Among flavonoids, chalcones and their derivatives are known for
their therapeutic effects as anti-inflammatory and anti-infective [29] or
anticancer agent [30]. It has been previously demonstrated the
cytotoxic effects of isobavachalcone on different carcinoma cell lines
[31]. Recently Kuete et al. evaluated the cytotoxic effects not only of the
chalcone isobavachalcone but also of others two flavonoids,
artocarpesin and cycloartocarpesin, on drug-sensitive cancer cell lines
and, for the first time, against MDR cancer cell lines. In particular, they
demonstrated that these compounds induce, on MDR leukemia cells
CCRF-CEM, apoptosis through activation of caspases, disruption of
mitochondrial membrane potential and generation of reactive oxygen
species (ROS) [32].
These results are promising and encouraging to further investigating
on the role of these constituents in order to find novel cytotoxic drugs
against multifactorial drug resistant cancers or compounds that are
effective with reduced toxicity.
Terpenes and terpenoids isolated from plants
Terpenes are a big class of organic molecules produced mainly by
conifers essential oils of the plant and generally used as natural
agricultural pesticides. The terpenes could be modified chemically
generating terpenoids that constitute about 60% of natural products.
Plant terpenes and mainly terpenoids are used as fragrances and as
traditional herbal remedies in alternative medicine. Because of their
antioxidative or anti-inflammatory properties, these compounds are
revalued as possible anticancer agents.
Triterpenoids induce cytotoxicity not only on sensitive leukemia cell
lines but also in MDR cells. Recent findings have shown that these
compounds interact with transporter proteins to inhibit drug efﬂux
mediated by MDR1, MRP1 or BCRP. In particular, triterpenoids can
act with different mechanisms, including direct interaction with the P-
glycoprotein (P-gp) active site, stimulating the activity of the P-gp
ATPase [33], or decreasing P-gp expression in a dose-dependent
manner [34].
Myrica cerifera
Myrica cerifera is a tree that grows in the northern and central parts
of America, Bermuda, and the Caribbean, commonly known as
bayberry or wax myrtle. Several compounds have been extracted from
the plant and some of them are known for their antioxidative and anti-
inflammatory properties [35] or for their in vitro anticancer potential
in some human cancer cell lines such as adenocarcinoma and prostate
cancer cells [36], glioblastoma and melanoma cells [37].
Recently, Zhang and collaborators demonstrated that seven different
triterpenoids isolated from the extract of M. cerifera bark hold
cytotoxic activities against human breast cancer cell line SK-BR-3 and
lung cancer cell line A549. Relatively to leukemia, they demonstrated
the cytotoxic effect of one specific triterpenoid on human leukemia cell
line HL60; furthermore their results showed that this compound
activates not only mitochondrial mediated apoptotic pathway, via
cleavage of caspase 3 and caspase 9, but also death-receptor mediated
apoptotic pathway, via cleavage of caspase 8 [38].
Melia azedarach
Melia azedarach is a plant that grows preferentially in India, Cina
and Australia. All components are tossic for humans if ingested, due to
some neurotoxins mainly contained in the fruit. For this reason,
ancients used the diluited infusion of leaves and bark to induce uterus
relaxation or as sedative. Many studies focused on different
compounds extracted from the plant, such as limonoids or
triterpenoids, that exert cytotoxic activities [39,40]. Recently, new
triterpenoids isolated from the fruit of Melia azedarach has been tested
on human cancer cell lines including human leukemia cell line HL60,
demonstrating their cytotoxicities thus opening new possibilities to use
M. azedarach also for anticancer therapy [41].
Asteraceae species (Artemisia Asiatica and Onopordum acanthium)
Asteracee, known also as Compositae, are a family of plants largely
diffuse. All the member of this family are enriched in secondary
metabolites, including sesquiterpene lactones and pentacyclic
triterpene alcohols and many of them are used to cure malignant
disorders [42]. In particular, the shrub wormwood or Artemisia
asiatica and the herbaceous plant of Onopordum acanthium are two
plants used in traditional medicine for many diseases including
cancers but their antiproliferative and cytostatic effects have been
tested only against human adherent cancer cell lines [43,44].
In literature, there are not data about specific compounds isolated
from these plants and their effects on Leukemia until 2015. Many
sesquiterpenes isolated from these two plants has been recently
investigated on human promyelocytic leukemia cells HL-60 in order to
identify their antiproliferative effects. In particular, it has been
demonstrated that four different sesquiterpenes exert these
antiproliferative effects on HL60 affecting cell cycle and inducing
apoptosis. The effects on cell cycle consist in an increase in the subG1
and G2/M populations, that indicate cell cycle arrest, while the
activation of apoptosis has been demonstrated by the activation of
caspase 9, as well as the nuclear fragmentation and the activation of
effector caspase 3 [45].
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Atractylodes lancea
Atractylodes lancea is a chinese herbal medicine. It is demonstrated
that essential oils extracted from its rhizome exert apoptotic activity on
human leukemia HL-60 cells. The main specific compounds
responsible of these effects are b-eudesmol and the sesquiterpenoid
hinesol [46]. Both compounds have cytotoxic activity on leukemic
HL60 cells mediated by activation of apoptosis; this pathway is
regulated by the activation of Jnk signaling, in the case of b-eudesmol
[47]; instead, the sesquiterpenoid hinesol exert its effect on apoptosis
through the regulation and balance between activation of the JNK and
ERK pathways [48].
Quercus suber L.
Quercus suber L. is a tree widely diffuse in southwest Europe and
northwest Africa, commonly known as cork oak. Recently, because of
its antioxidant effects, it has been revaluated for nutraceutical
applications. In particular, it seems that phenolic, aliphatic and
triterpenic components obtained from the cork are responsible of these
effects. A rising number of reports describe the pro-apoptotic effects of
natural compounds in cancer cells and their effects on radical
scavenging. Recently, Bejarano et al. described the antitumor effects of
Quercus suber L. cork extracts (QSE) in human promyelocytic
leukaemia cells HL-60, demonstrating that QSE is able to alter the
mitochondrial outer membrane potential, activate caspase 3 and
therefore induce apoptotic cancer cell death [48].
Lignans isolated from plants
Lignans are a large group of natural compounds extracted from
different plants commonly known for its antioxidant properties and in
balancing hormone levels.
Cinnamomum parthenoxylon: Cinnamomum is an evergreen tree
native to South and East Asia. Cinnamomum belongs to genera of
Lauraceae family that includes many species with different properties
and commonly used as spices in food or as fragrances. Furthermore
some of these species are used in traditional medicine and, relatively to
species parthenoxylon, it has been demonstrated that the extract of the
bark has antioxidant effects [49]. Several constituents of cinnamomum
species have cytotoxic and apoptotic activities on various cancer cell
lines [50]. Recently the scientific community investigate on possible
anticancer effects of different constituents derived from the species c.
parthenoxylon demonstrating the apoptotic effect of several lignans
and phenylpropanoids isolated from its wood on human hepatoma cell
line HUH-7 [51]. Adfa and colleagues demonstrate, in leukemia, that
some fractions of C. parthenoxylon are able to induce morphological
changes and to inhibit cell proliferation of leukemic cells HL-60 [52].
Nectandra megapotamica: Nectandra megapotamica is a plant
native to Brazil, belongs to genera of Lauraceae family. It has been used
in folk medicine to treat several diseases such as rheumatism and to
relieve pain. Moreover, it has been demonstrated that different
constituents isolated from the plant has pharmacological and
biological activities [53]. There are not any studies regarding the
cytotoxic activity against cancer cells of its extract and/or constituents
of nectandra megapotamica. Recently Ponci et al. described the
cytotoxic effects of different neolignans, extracted from the leaves of
the plant, on human leukemic cells HL-60, demonstrating that these
compounds exert their effects through activation of mitochondrial
apoptotic pathway [53].
Magnolia officinalis: Magnolia is a flowering tree native to many
regions in the world. Many species of Magnolia are traditionally used
in Asian medicine, mainly its neolignan honokiol, extracted from the
bark and the leaves of the tree. Honokiol is able to induce apoptosis
and cell cycle arrest in non-small cell lung cancer [54] and in adult T-
cell leukemia [55]. Recently it has been demonstrated that other
natural compounds extracted from plants, such as green tea
polyphenols and curcumin, exert their anti-cancer properties through
the inhibition of the HDAC activity [56,57]. Li et al. demonstrated that
honokiol inhibit cell growth of human leukemic cell lines and primary
AML blasts through the same pathway mediated by HDAC proteins,
thus suggesting honokiol as a novel nontoxic natural agent for cancer
prevention and therapy in leukemia [57].
Collectively these results lead to try also the application of lignans
extracted from different tree in the field of phytochemicals as
anticancer agents.
Essential oils of algae extracts
Microalgae are unicellular species found in marine systems and
generally used as biomass to produce energy. The biodiversity of
microalgae is enormous and they are very rich in bioactive
compounds, minerals, polysaccharides. Nowadays they are considered
an important source to discover new bioactive compounds.
The current chemotherapy for AML is based on cytarabine,
compound isolated from a marine sponge. There are few articles about
the apoptotic effects of algae extracts on cancer cells. Goh et al.
reported the apoptotic effects of Chaetoceros calcitrans microalga on
MDA-MB-231 breast cancer cells [58], Prestegard’s group instead
showed the apoptotic effect of P. tricornutum microalgae extract on
IPC81 rat myeloid leukemia cells [59]. Bechelli et al. showed that
Dunaliella salina and Aphanizomenon flos-aquae inhibit the growth of
both HL-60 and MV4-11 leukemic cell lines [60].
Recently it has been published a study on antileukemic activity of
fifteen microalgae species to verify their potential for drug
development. First of all the authors characterized the composition of
essential oils of these fifteen different algae extracts and tested the
different cytotoxic effects on HL60 and K562 leukemic cell lines.
Afterwards, they selected five essential oils and investigated the
pathways that determined the cytotoxic effects observed. This extracts
are able to inhibit the activity of Akt on HL60 cells, while others
increased the phosphorylation of MAPK on K562 cells finally
activating apoptotic pathway mainly mediated by cleaved caspase 3
and cleaved PARP and the bcl-2 family protein BAD. The isolation of
these essential oils from algae extract and their various combinations
can allow to find new antileukemic agents more efficient and to reduce
the toxicity because of their natural origin [61].
Extracellular vesicles in plants
Recently the interest of the scientific community toward
extracellular vesicles (EVs) is grown; in the contest of natural
compounds as new therapeutic molecules, the presence of exosomes in
edible plants is up to now very interesting.
Already exist publications that describe the release of exosomes
from tubers like carrot or ginger [62], from nuts and seeds sunflower
[63] or from fruits like grape, watermelon or lemon. It is known that
grapefruit nanovesicles, isolated from grape juice, act as immune
modulators in the intestine and are able to attenuate inflammatory
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response in human disease [64]; furthermore there are clinical trials
focus on their possible application to prevent cancer progression. It
was demonstrated the uptake of watermelon-derived EVs in Caco-2
cells and mouse small intestinal stem cells suggesting that EVs could be
the vehicle to transfer molecules in the intestine also due to their
capability to remain intact in the gastrointestinal tract [65]. Raimondo
et al. also demonstrated that the juice of citrus limon contains
exosome-like nanovesicles. The fruit of citrus L. is commonly used in
traditional medicine and its benefits are largely known, due to its
content of citric acid and vitamin C, but also for its anti-cancer
properties. In particular, they showed that these plant-derived
nanovesicles are able to affect cell growth of human colorectal
adenocarcinoma cells and leukemia cells. Furthermore, they confirmed
the results in vivo on CML xenografts demonstrating that citrus
nanovesicles reduce the growth of CML xenografts through activation
of TRAIL-mediated apoptosis but also through inhibition of
angiogenesis [66]. The authors show an alternative approach to cancer
therapy based on plant-derived nanovesicles with antineoplastic
capacity.
Differentiation inducers in AML and CML
Many natural compounds have been studied in these last years
because of they are able to affect not only cell differentiation of solid
tumors as chondrogenesis [67] and neuronal cells [68], but also of
bone marrow-derived hematopoietic cells. Although the main
differentiation inducer in acute promyelocytic leukemia therapy has
been all-trans retinoic acid (ATRA), these compounds can support
traditional anticancer chemotherapies or enhance the effect of ATRA
[69].
Flueggea suffruticosa: Securinine is an alkaloid isolated from the
flowering plant Flueggea suffruticosa, belonging to the family of
Phyllanthaceae and commonly used as herb in traditional chinese
medicine. Relatively to leukemia, Gupta et al. demonstrated that
securinine induces growth arrest in AML cell lines, patient samples
and AML tumors in nude mice thus confirming its possible
therapeutic role for AML treatment. Nowadays it is considered a
potential myeloid leukemia differentiation inducing agent; moreover it
was shown that securinine enhances the differentiating activities of
ATRA on leukemic HL60 cells, suggesting that this natural alkaloid
could also be used in a combination therapy [70].
Veratrum californicum: Cyclopamine is another alkaloid isolated
from the plant Veratrum californicum known as California corn lily,
native to southwestern North America. Cyclopamine is studied as
anticancer drug [71] and is also known to enhance HL60 cells
differentiation, similarly to securinine, in association with ATRA [72].
Scutellaria baicalensis Georgi: On the contrary, the flavonoids
wogonine and wogonoside induce AML cell differentiation
independently of ATRA [73]. Wogonine is isolated from the chinese
herb Scutellaria baicalensis Georgi, a flowering plant of the Lamiaceae 
family. It has been demonstrated that wogonine and its metabolite
wogonoside have antioxidant and anti-inflammatory effects [74];
moreover wogonine induce cell cycle arrest, apoptosis and
differentiation not only on different cancer cell lines [75], but also in
hematologic malignancies where it induces apoptosis on malignant
lymphocytes and suppresses cell growth of T-cells. Besides,
wogonoside affects differentiation, acting on human AML cells in vitro
and in vivo. In particular, wogonoside induces the monocytic
differentiation of lymphoma cell line U937 and leukemic cell line HL60
[76].
In addition, wogonine exerts effects on CML cell line K562 and,
interestingly, on imatinib resistant K562 cells.
Wogonine lead to differentiation of K562 cells, demonstrated by the
increased expression of many markers and by the cell cycle arrest at the
G0/G1 phase with inhibition of the MAPK pathway. Furthermore, it
exerts its effect also on differentiation of primary CML cells from
patients and on resistant K562 cells probably with a mechanism Bcr-
abl independent [77].
Another mechanism through which is reactivated erythroid
differentiation in K562 cells is the inhibition of heat shock protein
HSP90. Many natural compounds are able to do this in combination or
not with the inhibition of Bcr–Abl and finally activate the erythroid
transcription factor GATA-1. Wogonin induces erythroid
differentiation in K562 cells mediated by activation of GATA-1 and
inhibition of Bcr–Abl [77].
Monocillium nordinii and dandelion plant
The compounds radicicol, isolated from the mushroom
Monocillium nordinii, and apigetrin, extracted from the root of
dandelion plant, act on erythroid differentiation too. Radicicol exert its
effect on Bcr-Abl degradation and HSP90 inhibition through
increasing of GATA-1 and inhibition of the transcription factor PU.1,
an inhibitor of erythropoiesis [78]. Apigetrin induces the expression of
GATA-1 but also it is able to inhibit the expression of different
markers, such as CD11b (granulocyte), CD14 (monocyte) and CD41a
(megakaryocyte) [79]. These examples demonstrate that many
compounds extracted from different herbs or root exert their effect on
leukemia cell differentiation thus inhibiting, in an alternative way, cell
proliferation.
Efforts to combat cancers in terms of chemotherapeutic drugs have
not been effective enough and those that show promising results
exhibit side effects and poor bioavailability. Natural products, that are a
part of our daily diet or are easily obtained and disposable, have shown
considerable anti-neoplastic effects without causing side effects[80].
Here we showed some examples of natural compounds extracted from
plants and their role recently discovered as anti-leukemic agents.
Conclusion
Overall, plant extracts, which have historically been used as
therapeutic agents, are continuously revealing novel anticancer
properties and mechanisms and continue to hold prominent promise
in future cancer therapies. The experimental data showed here,
encourage the scientific community to enhance the research on drugs
of natural origin with lower toxicity and easily disposable that could be
used as valid alternative to chemotherapy or in combination with, thus
counteracting drug resistance, decreasing cytotoxic effects and
improving the patient's quality of life in leukemia as well as in other
cancer types.
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